Spero Therapeutics
SPRO
#9758
Rank
C$49.14 M
Marketcap
$0.88
Share price
-11.61%
Change (1 day)
-63.69%
Change (1 year)

Spero Therapeutics (SPRO) - Cash on Hand

Cash on Hand as of September 2024 : C$0.10 Billion

According to Spero Therapeutics's latest financial reports the company has C$0.10 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Spero Therapeutics - Cash on Hand chart (from 2016 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$0.10 B-31.62%
2022-12-31C$0.14 B-20.65%
2021-12-31C$0.18 B15.31%
2020-12-31C$0.16 B51.01%
2019-12-31C$0.10 B-31.86%
2018-12-31C$0.15 B43.3%
2017-12-31C$0.10 B691.69%
2016-12-31C$13.86 M75.59%
2015-12-31C$7.89 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$75.08 M-30.14%๐Ÿ‡บ๐Ÿ‡ธ USA
C$20.55 B 19,025.70%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.65 B 2,374.77%๐Ÿ‡จ๐Ÿ‡ฆ Canada